3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, Large B-Cell, Diffuse
40
Lymphoma, Mantle-Cell
27
Lymphoma
26
Lymphoma, Follicular
25
Lymphoma, Non-Hodgkin
23
Leukemia, Lymphocytic, Chronic, B-Cell
22
Lymphoma, B-Cell
14
Lymphoma, B-Cell, Marginal Zone
13
Burkitt Lymphoma
12
Recurrence
11
Precursor Cell Lymphoblastic Leukemia-Lymphoma
8
Neoplasms
8
Waldenstrom Macroglobulinemia
6
Leukemia, Hairy Cell
5
Lymphoproliferative Disorders
4
Leukemia
4
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
beta-Thalassemia
2
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
2
Neoplasm, Residual
2
Lymphatic Diseases
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Myeloid, Acute
2
Leukemia, Myeloid, Accelerated Phase
2
Leukemia, Biphenotypic, Acute
2
Leukemia, B-Cell
2
Infections
2
Hodgkin Disease
2
Hematologic Neoplasms
2
Epstein-Barr Virus Infections
2
Interventions
Cyclophosphamide
7
Biopsy
4
mogamulizumab
3
Specimen Handling
3
Peripheral Blood Stem Cell Transplantation
3
Etoposide
3
ruxolitinib
2
fludarabine phosphate
2
fludarabine
2
Whole-Body Irradiation
2
Vincristine
2
Tacrolimus
2
Prednisone
2
Nivolumab
2
Mycophenolic Acid
2
Magnetic Resonance Spectroscopy
2
Busulfan
2
tofacitinib
1
tazemetostat
1
talimogene laherparepvec
1
sodium-iodide symporter
1
pembrolizumab
1
hypericin
1
cemiplimab
1
belinostat
1
X-Rays
1
Vorinostat
1
Transplantation
1
Sirolimus
1
Radiotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, T-Cell, Cutaneous
×
Rituximab
×
90 days
×
Clear all
No trials found.